Skip to main content
All lobbying filings

SL STRATEGIES, LLC

SL STRATEGIES, LLC filed a Q3 report for PARTNER THERAPEUTICS on October 20, 2026, reporting $45,000 in lobbying income.

Lobbying for PARTNER THERAPEUTICS · biotechnology company

All filings by SL STRATEGIES, LLC · Everything PARTNER THERAPEUTICS has reported

 Filing · LD-2 quarterly report Q3 report
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 20, 2026
Income
$45,000
What the client paid this registrant for the period.
Client based in
Massachusetts

Official filing document

 Lobbyists on this filing 1
  • MARY MOODY JOHNSON
    Previously held: U.S. Senate Committee on Health, Education, Labor and Pensions

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

 Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 3

Issues related to rad/nuc preparedness and response; Pandemic All-Hazards Preparedness and Response

Fiscal Year 2027 HHS appropriations for rad/nuc preparedness and response, specifically within BARDA and the Strategic National Stockpile. Fiscal Year 2027 DOD appropriations for rad/nuc preparedness and response.

Issues related to rad/nuc preparedness and response.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem